Analysts’ Viewpoint
Rise in prevalence of neurological disorders such as stroke, Parkinson's disease, multiple sclerosis, cerebral palsy, traumatic brain injury, and spinal cord injury are driving the global market. Rise in awareness about neurorehabilitation devices among the population is a major factor expected to drive market expansion. Furthermore, increase in investment in R&D on neurorehabilitation products is likely to bolster global wearable neurorehabilitation devices market size in the next few years.
Launch of technologically advanced wearable neurorehabilitation devices offers lucrative offers to market players. Companies are focusing on increasing investment to enhance product offerings and expand global footprint. Post the COVID-19 pandemic, wearable brain neurorehabilitation device manufacturers are investing significantly in the development of advanced devices to increase sales.
Wearable neurorehabilitation devices are used to provide biofeedback about biomechanical or physiological body parameters to improve outcomes in people with neurological diseases. This is a promising approach that influences motor learning and patients’ engagement.
Wearable neurorehabilitation devices include force-based sensors, which are the most popular form utilized in wearable sensors for rehabilitation. Several forms of these sensors are used to provide auditory, visual, and biofeedback alongside force-based measurements. Force-based sensors include gyroscopes, accelerometers, and magnetometers.
Rise in prevalence of neurological diseases, such as Parkinson’s disease and stroke, is projected to drive the global wearable neurorehabilitation devices market growth. For instance, the World Health Organization (WHO) projects that by 2030, there will be 103 million patients suffering from neurological illnesses, up from 95 million in 2015.
These numbers highlight the need to reduce the occurrence of these illnesses, which will subsequently increase the requirement for neurorehabilitation equipment. Usage of neurorehabilitation equipment for the diagnosis and treatment of neurological diseases has increased as a result of rise in prevalence of neurological diseases.
According to the WHO, epilepsy is a widespread neurological condition that affects 50 million individuals across the globe (as of 2016), and 2.4 million new cases are reported each year. According to the World Economic Forum, there will be 8.7 million Parkinson's disease patients worldwide by 2030.
Introduction of wearable technology & robots and rise in expenditure on healthcare infrastructure are anticipated to bolster the global neurorehabilitation devices industry. Customers prefer to own a single, small gadget that can fulfil all of their computing and monitoring needs.
Development of innovative wearable neurorehabilitation devices by various companies is fueling market development. However, high cost of neurorehabilitation devices is likely to restrain market growth to some extent.
Research & development in wearable neurorehabilitation devices is anticipated to offer various opportunity to market players during the forecast period. For instance, Hand Extension Robot Orthosis (HERO) Grip Glove, a clinical trial product, was iteratively designed to meet requests from therapists and persons after a stroke who have severe hand impairment. The device extends all five fingers, enhances grip strength, and is portable, lightweight, easy to put on, comfortable and affordable. As per Myomo, Inc., its product MayoPal device is anticipated to launch by 2024 for pediatric patients with upper extremity paralysis.
Pipeline trials were conducted in 2021 for multiple sclerosis (MS) using EKSO GT exoskeleton. EKSO GT is an over-ground wearable exoskeleton developed and commercialized to train and improve gait in people with neurological diseases. This device reproduces physiological gait minimizing compensatory patterns and guiding recovery.
The COVID-19 pandemic has had a significant impact on the global market. The pandemic resulted in a temporary decline in the industry, as most healthcare providers redirected resources to prioritize the treatment of COVID-19 patients, leading to reduced demand for wearable neurorehabilitation.
Supply chain disruptions caused challenges in the production and distribution of wearable neurorehabilitation. Manufacturing delays, transportation constraints, and import/export restrictions led to potential shortages and limited availability of these products.
However, the COVID-19 pandemic created new challenges to patient care, imposing adaptation of healthcare facilities such as telemedicine for neurological diseases. Therefore, these efforts in the field of wearable neurorehabilitation devices are expected to fuel market expansion in the post-pandemic period.
In terms of application, the stroke segment accounted for the largest global wearable neurorehabilitation devices market share in 2022. The trend is expected to continue during the forecast period. This is ascribed to constant increase in incidence of stroke across the globe.
As per the Global Stroke Factsheet released in 2022, lifetime risk of developing a stroke has increased by 50% over the past 17 years; presently, 1 in 4 people is likely to have a stroke in the lifetime.
Based on end-user, the hospitals/clinics segment dominated the global wearable neurorehabilitation devices market in 2022. Hospitals and clinics serve as major healthcare providers and have the infrastructure and resources to perform neurological treatment procedures.
Rehabilitation centers was the second largest segment in 2022. This is ascribed to increase in treatment of neurological disorders, such as stroke, in rehabilitation centers across the globe.
As per wearable neurorehabilitation devices market trends, North America accounted for significant share in 2022. This is ascribed to high incidence of stroke and Parkinson’s disease, federal government funding, and investment in diagnosis & prevention of neurodegenerative diseases.
The U.S. and Canada are the major markets in North America. More than 130,000 people die each year in the U.S. due to stroke, and it is the leading cause of disability. Also, more than 400,000 people in Canada are suffering from long-term stroke disability.
North America is home to leading players such as Ekso Bionics Holdings, Inc., Flint Rehab, and Myomo, Inc. Adoption rate of wearable neurorehabilitation devices is expected to increase in the region, as the treatments are covered under the medical insurance plans and the average out-of-pocket expenses are high in the region.
Europe is expected to witness significant wearable neurorehabilitation devices market demand during the forecast period. This is ascribed to rise in patient base with neurological disorders and improving healthcare infrastructure. Moreover, companies are adopting strategic initiatives to expand operations in this region.
The wearable neurorehabilitation devices market report concludes with the company profiles section that includes key information about the major players. Companies focus on strategies such as new product launches, mergers, and partnerships & collaborations to compete in the marketplace.
Cadence Biomedical, Flint Rehab, Ekso Bionics Holdings, Inc., Myomo, Inc., and ReWalk Robotics are the prominent players in the market.
Prominent players have been profiled in the wearable neurorehabilitation devices industry research report based on parameters such as company overview, financial overview, strategies, portfolio, segments, and recent developments.
| Attribute | Details |
|---|---|
|
Size in 2022 |
US$ 552.8 Mn |
|
Forecast (Value) in 2031 |
US$ 1.7 Bn |
|
Growth Rate (CAGR) |
13.7% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Mn/Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 552.8 Mn in 2022.
It is projected to reach US$ 1.7 Bn by 2031.
It is anticipated to advance at a CAGR of 13.7% from 2023 to 2031.
Rise in prevalence of neurological disorders, technological advancements, and increase in product launches.
The stroke segment accounted for more than 40.0% share in 2022.
North America is expected to account for the largest share from 2023 to 2031.
Cadence Biomedical, Flint Rehab, Ekso Bionics Holdings, Inc., Myomo, Inc., and ReWalk Robotics.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Wearable Neurorehabilitation Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Forces Analysis
5. Key Insights
5.1. Technological Advancements
5.2. Regulatory Scenario
5.3. Reimbursement Scenario
5.4. COVID-19 Pandemic Impact on Industry
6. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by Application
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Application, 2017-2031
6.3.1. Stroke
6.3.2. Spinal Cord Injury
6.3.3. Cerebral Palsy
6.3.4. Others
6.4. Market Attractiveness Analysis, by Application
7. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals/Clinics
7.3.2. Rehabilitation Centers
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Wearable Neurorehabilitation Devices Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Wearable Neurorehabilitation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Application, 2017-2031
9.2.1. Stroke
9.2.2. Spinal Cord Injury
9.2.3. Cerebral Palsy
9.2.4. Others
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals/Clinics
9.3.2. Rehabilitation Centers
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Application
9.5.2. By End-user
9.5.3. By Country
10. Europe Wearable Neurorehabilitation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Application, 2017-2031
10.2.1. Stroke
10.2.2. Spinal Cord Injury
10.2.3. Cerebral Palsy
10.2.4. Others
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals/Clinics
10.3.2. Rehabilitation Centers
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Application
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Wearable Neurorehabilitation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Application, 2017-2031
11.2.1. Stroke
11.2.2. Spinal Cord Injury
11.2.3. Cerebral Palsy
11.2.4. Others
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals/Clinics
11.3.2. Rehabilitation Centers
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Application
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Wearable Neurorehabilitation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Application, 2017-2031
12.2.1. Stroke
12.2.2. Spinal Cord Injury
12.2.3. Cerebral Palsy
12.2.4. Others
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals/Clinics
12.3.2. Rehabilitation Centers
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Application
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Wearable Neurorehabilitation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Application, 2017-2031
13.2.1. Stroke
13.2.2. Spinal Cord Injury
13.2.3. Cerebral Palsy
13.2.4. Others
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals/Clinics
13.3.2. Rehabilitation Centers
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Application
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company (2022)
14.3. Company Profiles
14.3.1. Cadence Biomedical
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Product Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Flint Rehab
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Product Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Ekso Bionics Holdings, Inc.
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Product Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Myomo, Inc.
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Product Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. ReWalk Robotics
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Product Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
List of Tables
Table 01: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031
Table 02: Global Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 03: Global Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 06: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 07: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 08: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 09: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 10: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 11: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 12: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 13: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 14: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 15: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by Application, 2017-2031
Table 18: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 02: Global Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031
Figure 03: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Stroke, 2017-2031
Figure 04: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Spinal Cord Injury, 2017-2031
Figure 03: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Cerebral Palsy, 2017-2031
Figure 04: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Others, 2017-2031
Figure 05: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 06: Global Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by End-user, 2023-2031
Figure 07: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Hospitals/Clinics, 2017-2031
Figure 08: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Rehabilitation Centers, 2017-2031
Figure 09: Global Wearable Neurorehabilitation Devices Market Revenue (US$ Mn), by Others, 2017-2031
Figure 10: Global Wearable Neurorehabilitation Devices Market Value Share Analysis, by Region, 2022 and 2031
Figure 11: Global Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Region, 2023-2031
Figure 12: North America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 13: North America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country, 2022 and 2031
Figure 14: North America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country, 2023-2031
Figure 15: North America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 16: North America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031
Figure 17: North America Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 18: North America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, End-user, 2023-2031
Figure 19: Europe Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 20: Europe Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 21: Europe Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 22: Europe Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 23: Europe Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031
Figure 24: Europe Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 25: Europe Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by End-user, 2023-2031
Figure 26: Asia Pacific Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 27: Asia Pacific Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 28: Asia Pacific Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 29: Asia Pacific Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application, 2022 and 2031
Figure 30: Asia Pacific Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031
Figure 31: Asia Pacific Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 32: Asia Pacific Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by End-user, 2023-2031
Figure 33: Latin America Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 34: Latin America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 35: Latin America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 36: Latin America Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application 2022 and 2031
Figure 37: Latin America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031
Figure 38: Latin America Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 39: Latin America Wearable Neurorehabilitation Devices Market Attractiveness Analysis, End-user, 2023-2031
Figure 40: Middle East & Africa Wearable Neurorehabilitation Devices Market Value (US$ Mn) Forecast, 2017-2031
Figure 41: Middle East & Africa Wearable Neurorehabilitation Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 42: Middle East & Africa Wearable Neurorehabilitation Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 43: Middle East & Africa Wearable Neurorehabilitation Devices Market Value Share Analysis, by Application 2022 and 2031
Figure 44: Middle East & Africa Wearable Neurorehabilitation Devices Market Attractiveness Analysis, Application, 2023-2031
Figure 45: Middle East & Africa Wearable Neurorehabilitation Devices Market Value Share Analysis, by End-user, 2022 and 2031
Figure 46: Middle East & Africa Wearable Neurorehabilitation Devices Market Attractiveness Analysis, End-user, 2023-2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Wearable Neurorehabilitation Devices Market
*86 figures and 60 tables includes